MCFD2
Multiple coagulation factor deficiency protein 2
Also known as: F5F8D, LMAN1IP, MCFD2_HUMAN, SDNSF
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NI22
- Gene
- MCFD2
- Ensembl
- ENSG00000180398
- Chromosome
- 2
- Canonical length
- 146 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene encodes a soluble luminal protein with two calmodulin-like EF-hand motifs at its C-terminus. This protein forms a complex with LMAN1 (lectin mannose binding protein 1; also known as ERGIC-53) that facilitates the transport of coagulation factors V (FV) and VIII (FVIII) from the endoplasmic reticulum to the Golgi apparatus via an endoplasmic reticulum Golgi intermediate compartment (ERGIC). Mutations in this gene cause combined deficiency of FV and FVIII (F5F8D); a rare autosomal recessive bleeding disorder characterized by mild to moderate bleeding and coordinate reduction in plasma FV and FVIII levels. This protein has also been shown to maintain stem cell potential in adult central nervous system and is a marker for testicular germ cell tumors. The 3' UTR of this gene contains a transposon-like human repeat element named 'THE 1'. A processed RNA pseudogene of this gene is on chromosome 6p22.1. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Apr 2016]
Canonical amino-acid sequenceUniProt
146 residues, UniProt reviewed canonical sequence.
>Q8NI22|MCFD2
1 MTMRSLLRTP FLCGLLWAFC APGARAEEPA ASFSQPGSMG LDKNTVHDQE HIMEHLEGVI
61 NKPEAEMSPQ ELQLHYFKMH DYDGNNLLDG LELSTAITHV HKEEGSEQAP LMSEDELINI
121 IDGVLRDDDK NNDGYIDYAE FAKSLQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MCFD2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 146 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 146 nTPM
- salivary gland: 140 nTPM
- thyroid gland: 113 nTPM
- liver: 104 nTPM
- pancreas: 97 nTPM
- choroid plexus: 96 nTPM
Single-cell type
- salivary acinar cells: 354 nCPM
- müller glia: 289 nCPM
- esophageal apical cells: 280 nCPM
- pancreatic acinar cells: 243 nCPM
- breast lactating cells: 226 nCPM
- lacrimal acinar cells: 215 nCPM
Immune cell
- eosinophil: 30 nTPM
- basophil: 27 nTPM
- intermediate monocyte: 23 nTPM
- classical monocyte: 22 nTPM
- myeloid DC: 19 nTPM
- non-classical monocyte: 18 nTPM
Brain region
- choroid plexus: 182 nTPM
- hypothalamus: 130 nTPM
- pons: 121 nTPM
- midbrain: 118 nTPM
- basal ganglia: 118 nTPM
- cerebral cortex: 115 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MCFD2.
Disease | AllUniProt
Conditions MCFD2 is implicated in, by any mechanism.
- Factor V and factor VIII combined deficiency 2 (F5F8D2) MIM:613625
Disease | GeneticClinVar
12 pathogenic / likely-pathogenic of 174 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Factor 5 and Factor VIII, combined deficiency of, 2
- Factor V and factor VIII, combined deficiency of, type 1
- MCFD2-related disorder
- Reduced quantity of Von Willebrand factor
- Reduced von Willebrand factor activity
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.27
- gnomAD pLI
- 0.1
- gnomAD missense Z
- -0.58
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MCFD2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MCFD2 as an antibody target. Whether an autoantibody or antibody against MCFD2 could matter depends on whether native MCFD2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MCFD2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MCFD2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...